0.0002
0.0000
(0.00%)
At close: January 31 at 3:00:00 PM EST
Breakdown
TTM
Operating Cash Flow
-31,952.0000
Investing Cash Flow
358.0000
Financing Cash Flow
19,028.0000
End Cash Position
8,086.0000
Issuance of Capital Stock
16,535.0000
Free Cash Flow
-31,952.0000
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
OVIT OncoVista Innovative Therapies, Inc.
0.0002
0.00%
BETRF BetterLife Pharma Inc.
0.0890
0.00%
MOLN Molecular Partners AG
5.16
-3.55%
IMUC EOM Pharmaceuticals Holdings, Inc.
0.1600
0.00%
KLTO Klotho Neurosciences, Inc.
0.3800
-3.94%
IMRN Immuron Limited
2.0420
-4.58%
TXTM ProText Mobility, Inc.
0.0010
+11.11%
GDTC CytoMed Therapeutics Limited
2.6400
+5.18%
AKTX Akari Therapeutics, Plc
1.0900
-18.05%
TLPPF Telix Pharmaceuticals Limited
17.99
0.00%